Skip to main content

Table 1 Patient characteristics at baseline (all patients (n = 43))

From: Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study)

Median age (range) 85 (80–96)
No. of females (%) 15 (35)
No. of males (%) 28 (65)
Median no. of comorbidities (IQR) 3 (2–4)
Median no. of concomitant medications (IQR) 6 (3–9)
Median total OABSS (IQR) 9 (8–11)
Median total IPSS (IQR) 15 (9.5–21)
Median IPSS QOL score (IQR) 5 (4–6)
Median voiding volume (ml) according to UFM (IQR) 106.35 (56.8–132.8)
Median maximum flow rate (ml/s) (IQR) 9.2 (5.4–12.7)
Median PVR (ml) (IQR) 15 (6.5–26.8)
Median VES-13 score (IQR) 6 (3–8)
Median MMSE score (IQR) 27 (25–28)
Median heart rate (beats/min) (IQR) 64 (57–73)
Median QT interval corrected using Fridericia’s formula (ms) (IQR) 419 (397.25–438)